News and stories

The LMAC Group has built a new mobile showcase experience focused on digital technologies designed to help New Zealand companies harness the opportunity to become more productive and profitable.

It’s been a big year for Easy Crypto, which last month launched its stablecoin, the NZDD, as well as a digital wallet for its customers.

At a glance Previously focussed on animal probiotics, a meeting with Callaghan Innovation at Fieldays® opened the way for BioBrew to move into human health supplements.

At a glance Engaging with the New Zealand Food Innovation Network, Synlait has gained access to a range of expertise and skilled technicians and has also allowed them to invest heavily in innovation projects, including a Tetra Pak-built UHT pilot plant.

At a glance A lot of meat alternatives produced in New Zealand were using imported proteins.

At a glance Looking to create new market opportunities, New Zealand seafood giant Sanford wanted to create new products derived from seafood, such as nutraceuticals.

At a glance Looking to capitalise on a multi-billion dollar industry, Pure Heart Aotearoa has produced a ready-to-drink hemp milk to sit alongside their other products, such as hemp oil.

At a glance Foodtech startup Nuka is producing a liquid smoke from kānuka plants, using it to flavour food with an instant hāngī taste.

At a glance Before gaining one of the first commercial licences in New Zealand to grow and supply cannabis-derived medicines, Rua Bioscience spent years investing in R&D projects and developing their facilities.

At a glance Saflex Pumps had already developed chemical dispensing equipment for the dairy industry.

At a glance In the face of different global trends, Leaft Foods looked to develop a high-value, sustainable leaf protein concentrate which has a lighter environmental footprint than alternative products.

At a glance Helico is aiming to produce therapeutic compounds from plants and, ultimately, ‘edible medicine’, with the technology potentially increasing accessibility and affordability of essential medicines.